These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25149560)

  • 1. Development and validation of a gene profile predicting benefit of postmastectomy radiotherapy in patients with high-risk breast cancer: a study of gene expression in the DBCG82bc cohort.
    Tramm T; Mohammed H; Myhre S; Kyndi M; Alsner J; Børresen-Dale AL; Sørlie T; Frigessi A; Overgaard J
    Clin Cancer Res; 2014 Oct; 20(20):5272-80. PubMed ID: 25149560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the prognostic and predictive value of the intrinsic subtypes and a validated gene profile predictive of loco-regional control and benefit from post-mastectomy radiotherapy in patients with high-risk breast cancer.
    Tramm T; Kyndi M; Myhre S; Nord S; Alsner J; Sørensen FB; Sørlie T; Overgaard J
    Acta Oncol; 2014 Oct; 53(10):1337-46. PubMed ID: 24957550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locoregional recurrence risk factors and the impact of postmastectomy radiotherapy on patients with tumors 5 cm or larger.
    Nagao T; Kinoshita T; Tamura N; Hojo T; Morota M; Kagami Y
    Breast Cancer; 2014 May; 21(3):292-301. PubMed ID: 22890603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies.
    ; Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J
    J Clin Oncol; 2006 May; 24(15):2268-75. PubMed ID: 16618947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials.
    Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J
    Radiother Oncol; 2006 May; 79(2):147-55. PubMed ID: 16647152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
    Fodor J; Polgár C; Major T; Németh G
    Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy.
    Tendulkar RD; Rehman S; Shukla ME; Reddy CA; Moore H; Budd GT; Dietz J; Crowe JP; Macklis R
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e577-81. PubMed ID: 22560546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chest wall radiotherapy: middle ground for treatment of patients with one to three positive lymph nodes after mastectomy.
    Macdonald SM; Abi-Raad RF; Alm El-Din MA; Niemierko A; Kobayashi W; McGrath JJ; Goldberg SI; Powell S; Smith B; Taghian AG
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1297-303. PubMed ID: 19327896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients.
    Cheng SH; Horng CF; Clarke JL; Tsou MH; Tsai SY; Chen CM; Jian JJ; Liu MC; West M; Huang AT; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1401-9. PubMed ID: 16472935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes.
    Moo TA; McMillan R; Lee M; Stempel M; Patil S; Ho A; El-Tamer M
    Ann Surg Oncol; 2013 Oct; 20(10):3169-74. PubMed ID: 23975289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
    J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram Predicting Locoregional Recurrence to Assist Decision-Making of Postmastectomy Radiation Therapy in Patients With T1-2N1 Breast Cancer.
    Luo C; Zhong X; Deng L; Xie Y; Hu K; Zheng H
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):905-912. PubMed ID: 30419307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation.
    Jagsi R; Raad RA; Goldberg S; Sullivan T; Michaelson J; Powell SN; Taghian AG
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1035-9. PubMed ID: 15990006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of molecular subtypes, ki67 expression and impact of postmastectomy radiation therapy in breast cancer patients with negative lymph nodes after mastectomy.
    Selz J; Stevens D; Jouanneau L; Labib A; Le Scodan R
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1123-32. PubMed ID: 22572073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy.
    Truong PT; Lesperance M; Culhaci A; Kader HA; Speers CH; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):175-82. PubMed ID: 15850919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for locoregional recurrence after mastectomy in stage T1 N0 breast cancer.
    Hastings J; Iganej S; Huang C; Huang R; Slezak J
    Am J Clin Oncol; 2014 Oct; 37(5):486-91. PubMed ID: 23428949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locoregional failure in early-stage breast cancer patients treated with radical mastectomy and adjuvant systemic therapy: which patients benefit from postmastectomy irradiation?
    Trovo M; Durofil E; Polesel J; Roncadin M; Perin T; Mileto M; Piccoli E; Quitadamo D; Massarut S; Carbone A; Trovo MG
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e153-7. PubMed ID: 22386375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of node-negative breast cancer 5 centimeters and larger treated with and without postmastectomy radiotherapy.
    Goulart J; Truong P; Woods R; Speers CH; Kennecke H; Nichol A
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):758-64. PubMed ID: 20646860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of locoregional outcome in patients receiving neoadjuvant therapy and postmastectomy radiation.
    Wright JL; Takita C; Reis IM; Zhao W; Saigal K; Wolfson A; Markoe A; Moller M; Hurley J
    Cancer; 2013 Jan; 119(1):16-25. PubMed ID: 22736498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.